
  
    
      
        Background_NNP
        Amyotrophic_NNP lateral_NN sclerosis_NN (_( ALS_NNP )_) is_VBZ an_DT age-dependent_JJ
        neurodegenerative_JJ disease_NN that_WDT causes_NNS progressive_JJ
        motoneuron_NN degeneration_NN ,_, skeletal_NN muscle_NN atrophy_NN ,_, paralysis_NN
        and_CC death_NN [_NN 1_CD 2_CD 3_CD ]_NN ._. Although_IN clinically_RB
        indistinguishable_JJ ,_, the_DT majority_NN of_IN cases_NNS are_VBP sporadic_JJ
        (_( SALS_NNP )_) and_CC approximately_RB 10_CD %_NN are_VBP due_JJ to_TO inherited_VBN causes_NNS
        (_( familial_NN ALS_NNP or_CC FALS_NNP )_) ._. Of_IN the_DT FALS_NNP cases_NNS about_IN 20_CD %_NN are_VBP due_JJ
        to_TO mutations_NNS in_IN SOD_NNP 1_CD [_NN 4_CD ]_NN ._. Rodents_NNP transgenic_JJ for_IN mutant_JJ
        human_JJ SOD_NNP 1_CD develop_VB progressive_JJ skeletal_NN muscle_NN atrophy_NN ,_,
        paralysis_NN and_CC death_NN similar_JJ to_TO human_JJ cases_NNS [_NN 5_CD 6_CD 7_CD 8_CD ]_NN ._.
        The_DT disease_NN causing_VBG property_NN of_IN mutant_JJ SOD_NNP 1_CD is_VBZ independent_JJ
        of_IN the_DT normal_JJ SOD_NNP 1_CD activity_NN ,_, and_CC thus_RB ,_, mutant_JJ SOD_NNP 1_CD kills_VBZ
        motor_NN neurons_NNS by_IN gaining_VBG a_DT toxic_JJ property_NN (_( reviewed_VBN in_IN [_NN 9_CD
        10_CD ]_NN )_) ._.
        Pathological_NNP examination_NN of_IN transgenic_JJ mice_NNS revealed_VBD
        early_JJ changes_NNS that_WDT are_VBP not_RB prominent_JJ in_IN human_JJ spinal_JJ cord_NN
        autopsies_NNS at_IN the_DT terminal_NN disease_NN stage_NN ._. These_DT changes_NNS
        include_VBP astrogliosis_NNS ,_, fragmentation_NN of_IN Golgi_NNP apparatus_NN ,_,
        SOD_NNP 1_CD aggregation_NN and_CC vacuolar_NN degeneration_NN [_NN 7_CD 11_CD 12_CD 13_CD 14_CD
        ]_NN ._. Vacuolar_NNP degeneration_NN is_VBZ most_RBS prominent_JJ at_IN the_DT onset_NN of_IN
        the_DT disease_NN and_CC precedes_VBZ motoneuron_NN death_NN by_IN two_CD to_TO three_CD
        months_NNS [_NN 15_CD ]_NN ._. Although_IN the_DT high_JJ expresser_NN line_NN of_IN SOD_NNP 1_CD
        G_NNP 93_CD Ashowed_NNP vacuoles_NNS derived_VBN from_IN both_DT endoplasmic_JJ reticulum_NN
        and_CC mitochondria_NN [_NN 13_CD ]_NN ,_, the_DT lower_JJR expresser_NN line_NN of_IN SOD_NNP 1_CD
        G_NNP 93_CD A_DT ,_, which_WDT more_RBR closely_RB mimics_VBZ the_DT human_JJ SOD_NNP 1_CD levels_NNS [_NN 16_CD
        ]_NN ,_, showed_VBD vacuoles_NNS that_WDT are_VBP nearly_RB all_DT developed_VBN from_IN
        degenerating_VBG mitochondria_NN [_NN 15_CD 17_CD ]_NN ._. Mitochondrial_NNP
        vacuolation_NN was_VBD also_RB reported_VBN in_IN another_DT transgenic_JJ line_NN
        SOD_NNP 1_CD G_NNP 37_CD R_NN [_NN 7_CD ]_NN ._.
        The_DT early_JJ onset_NN of_IN mitochondrial_NN degeneration_NN suggests_VBZ
        that_IN mutant_JJ SOD_NNP 1_CD damages_NNS mitochondria_NN and_CC this_DT damage_NN plays_VBZ
        a_DT causative_JJ role_NN in_IN motoneuron_NN degeneration_NN ._. Increasing_VBG
        evidence_NN supports_VBZ this_DT proposal_NN ._. Mutant_NNP SOD_NNP 1_CD causes_NNS
        dysfunction_NN and_CC structural_JJ damage_NN of_IN mitochondria_NN in_IN
        cultured_JJ neuronal_NN cells_NNS [_NN 18_CD 19_CD 20_CD ]_NN and_CC at_IN early_JJ disease_NN
        stages_NNS in_IN mutant_JJ SOD_NNP 1_CD transgenic_JJ mice_NNS [_NN 21_CD 22_CD ]_NN ._. Human_NNP ALS_NNP
        also_RB shows_VBZ mitochondrial_NN damage_NN ,_, dysfunction_NN and_CC loss_NN [_NN 23_CD
        24_CD ]_NN ._. The_DT mechanism_NN whereby_WRB mutant_JJ SOD_NNP 1_CD causes_NNS
        mitochondrial_NN damage_NN has_VBZ not_RB been_VBN determined_VBN ,_, but_CC recent_JJ
        evidence_NN shows_VBZ that_IN mutant_JJ SOD_NNP 1_CD is_VBZ imported_VBN into_IN
        mitochondria_NN [_NN 21_CD 25_CD 26_CD ]_NN ,_, and_CC this_DT mitochondrial_NN
        localization_NN may_MD cause_VB direct_JJ damage_NN to_TO mitochondria_NN and_CC
        induce_VB cell_NN death_NN [_NN 27_CD ]_NN ._. Consistent_NNP with_IN this_DT
        possibility_NN ,_, previous_JJ work_NN suggested_VBD that_DT mitochondrial_NN
        vacuolation_NN was_VBD developed_VBN from_IN expansion_NN of_IN the_DT
        intermembrane_NN space_NN [_NN 17_CD ]_NN ._. However_RB ,_, the_DT possibility_NN that_IN
        the_DT vacuoles_NNS represent_VBP autophagic_JJ vacuolation_NN has_VBZ not_RB been_VBN
        ruled_VBN out_IN ,_, because_IN the_DT source_NN of_IN the_DT vacuolar_NN membrane_NN was_VBD
        not_RB known_VBN ._.
        In_IN the_DT current_JJ work_NN we_PRP sought_VBD to_TO determine_VB whether_IN the_DT
        vacuoles_NNS are_VBP developed_VBN from_IN autophagy_NN ,_, MPT_NNP or_CC another_DT
        mechanism_NN ._. We_PRP examined_VBD vacuoles_NNS using_VBG transmission_NN electron_NN
        microscopy_NN (_( TEM_NNP )_) ,_, immunogold_NN electron_NN microscopy_NN and_CC
        immunoflouresence_NN microscopy_NN ._. We_PRP present_JJ new_JJ evidence_NN that_IN ,_,
        together_RB with_IN the_DT published_VBN literature_NN [_NN 17_CD ]_NN ,_,
        unequivocally_RB demonstrates_VBZ that_IN vacuoles_NNS are_VBP developed_VBN by_IN
        expansion_NN of_IN mitochondrial_NN intermembrane_NN space_NN and_CC
        extension_NN of_IN the_DT outer_JJ membrane_NN ._. This_DT is_VBZ neither_DT autophagy_NN
        nor_CC MPT_NNP ,_, but_CC a_DT new_JJ mitochondrial_NN degeneration_NN mechanism_NN in_IN
        the_DT CNS_NNP ._.
      
      
        Results_NNS
        Patterns_NNS of_IN mitochondrial_NN abnormalities_NNS revealed_VBN by_IN
        transmission_NN electron_NN microscopy_NN (_( TEM_NNP )_) suggest_VBP a_DT model_NN of_IN
        vacuole_NN formation_NN by_IN extension_NN of_IN mitochondrial_NN outer_JJ
        membrane_NN and_CC expansion_NN of_IN the_DT intermembrane_NN space_NN (_( Fig_NNP ._. 1_LS )_) ._.
        Vacuoles_NNP might_MD be_VB initiated_VBN at_IN focal_JJ weakening_NN of_IN inner_JJ and_CC
        outer_JJ mitochondrial_NN membrane_NN contact_NN ,_, resulting_VBG in_IN small_JJ
        protrusions_NNS from_IN the_DT outer_JJ membrane_NN (_( Fig_NNP ._. 1_LS A_DT ,_, arrow_NN )_) ._. This_DT
        protrusion_NN might_MD then_RB expand_VB (_( Fig_NNP ._. 1_LS B_NNP ,_, 1_CD C_NNP ,_, arrows_NNS )_) ,_, leading_VBG
        to_TO further_VB detachment_NN of_IN the_DT outer_JJ membrane_NN from_IN the_DT inner_JJ
        membrane_NN (_( Fig_NNP ._. 1_LS D_NNP ,_, 1_CD E_NNP ,_, unfilled_JJ arrowheads_NNS )_) ._. Eventually_RB the_DT
        mature_VBP vacuoles_NNS form_VBP (_( Fig_NNP ._. 1_LS F_NN ,_, 1_CD G_NNP ,_, 1_CD H_NNP ,_, 1_CD I_PRP )_) ,_, which_WDT contain_VBP
        inner_JJ membrane_NN remnants_NNS (_( Fig_NNP ._. 1_LS F_NN ,_, 1_CD G_NNP ,_, 1_CD I_PRP ,_, large_JJ arrows_NNS )_) and_CC
        vesicular_NN structures_NNS (_( Fig_NNP ._. 1_LS H_NNP ,_, 1_CD I_PRP ,_, unfilled_JJ arrows_NNS )_) ._. Often_RB
        noticeable_JJ is_VBZ the_DT discontinuity_NN in_IN the_DT vacuolar_NN membrane_NN in_IN
        large_JJ vacuoles_NNS (_( Fig_NNP ._. 1_LS D_NNP ,_, 1_CD I_PRP ,_, small_JJ arrows_NNS )_) ,_, suggesting_VBG that_IN
        as_IN the_DT vacuoles_NNS expand_VBP the_DT vacuolar_NN membrane_NN becomes_VBZ
        porous_JJ ._.
        To_TO test_VB this_DT model_NN ,_, we_PRP immunologically_RB located_VBN the_DT inner_JJ
        and_CC outer_JJ membrane_NN components_NNS in_IN the_DT vacuoles_NNS ._. We_PRP took_VBD
        advantage_NN of_IN a_DT previous_JJ observation_NN that_IN SOD_NNP 1_CD marks_NNS the_DT
        boundary_NN of_IN vacuoles_NNS [_NN 17_CD 28_CD ]_NN and_CC doubly_RB stained_JJ spinal_JJ
        cord_NN sections_NNS with_IN antibodies_NNS against_IN SOD_NNP 1_CD and_CC cytochrome_NN c_SYM
        oxidase_NN subunit_NN 1_CD (_( CO_NNP 1_LS )_) ,_, an_DT inner_JJ mitochondrial_NN membrane_NN
        marker_NN ._. CO_NNP 1_CD and_CC the_DT inner_JJ membrane_NN structure_NN are_VBP located_VBN
        focally_RB within_IN the_DT boundary_NN of_IN vacuoles_NNS (_( Fig_NNP ._. 2_LS A_DT ,_, 2_CD B_NNP ,_, 2_CD C_NNP ,_, 2_CD D_NNP )_) ._.
        Intense_JJ SOD_NNP 1_CD signal_NN is_VBZ located_VBN both_DT at_IN the_DT boundary_NN of_IN the_DT
        vacuoles_NNS and_CC inside_IN (_( Fig_NNP ._. 2_LS A_DT ,_, 2_CD B_NNP ,_, 2_CD C_NNP ,_, 2_CD D_NNP )_) ,_, most_JJS of_IN which_WDT
        appear_VBP to_TO be_VB associated_VBN with_IN membranes_NNS (_( Fig_NNP ._. 2_LS C_NNP ,_, 2_CD D_NNP )_) ._.
        Next_JJ ,_, we_PRP doubly_RB stained_JJ spinal_JJ cord_NN sections_NNS with_IN
        antibodies_NNS against_IN SOD_NNP 1_CD and_CC two_CD protein_NN subunits_NNS of_IN TOM_NNP
        (_( translocator_NN of_IN outer_JJ membrane_NN )_) ,_, TOM_NNP 20_CD and_CC TOM_NNP 40_CD ._. Both_DT are_VBP
        outer_JJ mitochondrial_NN membrane_NN proteins_NNS [_NN 29_CD ]_NN ._. Similar_JJ to_TO
        Figure_NN 2_CD ,_, SOD_NNP 1_CD signal_NN marked_VBD the_DT boundary_NN of_IN a_DT
        barrel-shaped_JJ vacuole_NN (_( Fig_NNP ._. 3_LS A_DT ,_, 3_CD D_NNP )_) ._. In_IN contrast_NN to_TO the_DT
        location_NN of_IN the_DT CO_NNP 1_CD signal_NN (_( Fig_NNP ._. 2_LS )_) ,_, TOM_NNP 20_CD /_NN 40_CD signals_NNS are_VBP
        at_IN the_DT boundary_NN of_IN the_DT vacuole_NN (_( Fig_NNP ._. 3_LS B_NNP ,_, 3_CD E_NNP )_) ,_, partially_RB
        overlapping_VBG with_IN the_DT SOD_NNP 1_CD signal_NN (_( Fig_NNP ._. 3_LS C_NNP ,_, 3_CD F_NN ,_, small_JJ
        arrows_NNS )_) ._. TOM_NNP 20_CD /_NN 40_CD signals_NNS are_VBP patchy_NN ,_, concentrated_VBN in_IN
        certain_JJ areas_NNS of_IN the_DT vacuolar_NN boundary_NN (_( large_JJ arrows_NNS )_) ._.
        Because_IN TOM_NNP 20_CD /_NN 40_CD staining_VBG also_RB labeled_VBN many_JJ normal_JJ
        mitochondria_NN outside_IN of_IN the_DT vacuoles_NNS ,_, the_DT signal_NN near_IN the_DT
        vacuole_NN obscured_VBD the_DT signal_NN associated_VBN with_IN the_DT vacuole_NN ._.
        This_DT left_VBD open_VB the_DT possibility_NN that_IN the_DT TOM_NNP 20_CD /_NN 40_CD signal_NN at_IN
        the_DT boundary_NN of_IN the_DT vacuole_NN represents_VBZ surrounding_VBG
        mitochondria_NN ,_, which_WDT are_VBP compressed_VBN by_IN the_DT expanding_VBG
        vacuole_NN ._. Although_IN this_DT possibility_NN is_VBZ inconsistent_JJ with_IN the_DT
        absence_NN of_IN CO_NNP 1_CD signal_NN at_IN the_DT vacuolar_NN boundary_NN (_( Fig_NNP ._. 2_LS )_) ,_, we_PRP
        further_RBR examined_VBD this_DT possibility_NN by_IN cutting_VBG a_DT middle_JJ
        section_NN of_IN the_DT vacuole_NN out_IN and_CC visualized_JJ it_PRP in_IN three_CD
        dimensions_NNS (_( Fig_NNP ._. 4_LS )_) ._. The_DT patches_NNS of_IN TOM_NNP 20_CD /_NN 40_CD signals_NNS (_( Fig_NNP ._.
        4_LS B_NNP ,_, 4_CD E_NNP ,_, arrows_NNS )_) did_VBD form_NN a_DT ring_NN around_IN the_DT vacuole_NN ,_, and_CC this_DT
        ring_NN overlaps_NNS with_IN the_DT inner_JJ boundary_NN of_IN the_DT ring_NN formed_VBN by_IN
        the_DT SOD_NNP 1_CD signal_NN (_( Fig_NNP ._. 4_LS C_NNP ,_, 4_CD F_NN )_) ._. This_DT indicates_VBZ that_DT
        mitochondrial_NN outer_JJ membrane_NN forms_VBZ the_DT boundary_NN of_IN vacuoles_NNS
        and_CC mutant_JJ SOD_NNP 1_CD may_MD be_VB attached_VBN to_TO the_DT outside_JJ of_IN the_DT
        vacuolar_NN membrane_NN ._.
        Is_VBZ cytochrome_NN c_SYM ,_, an_DT intermembrane_NN space_NN protein_NN ,_, present_JJ
        in_IN the_DT expanded_VBN intermembrane_NN space_NN ?_. To_TO answer_VB this_DT
        question_NN ,_, we_PRP doubly_RB stained_JJ spinal_JJ cord_NN sections_NNS with_IN
        antibodies_NNS against_IN SOD_NNP 1_CD and_CC cytochrome_NN c_SYM ._. Inside_IN large_JJ
        vacuoles_NNS cytochrome_NN c_SYM signal_NN is_VBZ absent_JJ (_( Fig_NNP ._. 5_LS A_DT ,_, 5_CD B_NNP ,_, 5_CD C_NNP ,_, 5_CD D_NNP )_) ._.
        On_IN the_DT other_JJ hand_NN ,_, small_JJ vacuoles_NNS contain_VBP abundant_JJ
        cytochrome_NN c_SYM signal_NN ,_, which_WDT nearly_RB completely_RB overlaps_NNS with_IN
        the_DT SOD_NNP 1_CD signal_NN (_( Fig_NNP ._. 5_LS E_NNP ,_, 5_CD F_NN ,_, 5_CD G_NNP ,_, 5_CD H_NNP ,_, arrows_NNS )_) ._. As_IN a_DT control_NN ,_,
        we_PRP also_RB examined_VBD small_JJ vacuoles_NNS doubly_RB stained_JJ with_IN SOD_NNP 1_CD
        and_CC CO_NNP 1_CD antibodies_NNS ._. CO_NNP 1_CD is_VBZ still_RB localized_JJ focally_RB in_IN these_DT
        small_JJ vacuoles_NNS (_( Fig_NNP ._. 5_LS I_PRP ,_, 5_CD J_NNP ,_, 5_CD K_NNP ,_, 5_CD L_NNP ,_, arrows_NNS )_) and_CC only_RB
        partially_RB overlaps_NNS with_IN SOD_NNP 1_CD signal_NN ._. Together_RB ,_, these_DT
        observations_NNS suggest_VBP that_DT cytochrome_NN c_SYM is_VBZ present_JJ in_IN the_DT
        intermembrane_NN space_NN of_IN the_DT early_JJ ,_, small_JJ vacuoles_NNS and_CC either_CC
        being_VBG diluted_VBN to_TO below_IN the_DT detection_NN levels_NNS in_IN large_JJ ,_,
        intact_JJ vacuoles_NNS ,_, or_CC leaked_VBD out_IN in_IN the_DT late_JJ ,_, large_JJ vacuoles_NNS
        because_IN of_IN porous_JJ nature_NN of_IN the_DT large_JJ vacuoles_NNS (_( Figs_NNP ._. 1_LS ,_,
        2_CD and_CC 5_LS )_) ._.
        In_IN normal_JJ mitochondria_NN the_DT outer_JJ membrane_NN wraps_VBZ closely_RB
        around_IN the_DT inner_JJ membrane_NN and_CC is_VBZ not_RB folded_VBN like_IN the_DT inner_JJ
        membrane_NN ._. Therefore_RB ,_, for_IN the_DT outer_JJ membrane_NN to_TO extend_VB ,_,
        additional_JJ membrane_NN would_MD be_VB needed_VBN ._. Because_IN ,_, in_IN addition_NN
        to_TO mitochondria_NN ,_, peroxisomes_NNS are_VBP also_RB involved_VBN in_IN
        phospholipid_NN synthesis_NN and_CC metabolism_NN (_( see_VB Discussion_NNP )_) ,_, we_PRP
        examined_VBD whether_IN peroxisomes_NNS might_MD participate_VB in_IN vacuole_NN
        formation_NN ._. Vacuoles_NNP contain_VB many_JJ catalase-positive_JJ
        granules_NNS ,_, the_DT vast_JJ majority_NN of_IN which_WDT are_VBP positioned_VBN closely_RB
        against_IN the_DT inner_JJ vacuolar_NN wall_NN (_( Fig_NNP ._. 6_CD B_NNP ,_, 6_CD C_NNP ,_, 6_CD D_NNP ,_, 6_CD F_NN ,_, 6_CD G_NNP ,_, 6_CD H_NNP ,_,
        filled_VBN arrows_NNS )_) ._. A_DT small_JJ minority_NN of_IN these_DT granules_NNS are_VBP
        attached_VBN to_TO the_DT outside_JJ of_IN the_DT vacuolar_NN wall_NN (_( Fig_NNP ._.
        6_CD B_NNP ,_, 6_CD C_NNP ,_, 6_CD D_NNP ,_, 6_CD F_NN ,_, 6_CD G_NNP ,_, 6_CD H_NNP ,_, unfilled_JJ arrows_NNS )_) ._. Similarly_RB ,_, numerous_JJ
        PMP_NNP 70_CD -_: positive_JJ granules_NNS are_VBP observed_VBN close_RB to_TO the_DT inner_JJ
        wall_NN of_IN the_DT vacuole_NN (_( Fig_NNP ._. 6_CD J_NNP ,_, 6_CD K_NNP ,_, 6_CD L_NNP ,_, filled_VBN arrows_NNS )_) and_CC a_DT
        small_JJ number_NN of_IN these_DT granules_NNS are_VBP attached_VBN to_TO the_DT outside_JJ
        (_( Fig_NNP ._. 6_CD J_NNP ,_, 6_CD K_NNP ,_, 6_CD L_NNP ,_, unfilled_JJ arrows_NNS )_) ._. Furthermore_RB ,_, catalase_NN
        signal_NN is_VBZ present_JJ together_RB with_IN CO_NNP 1_CD signal_NN in_IN the_DT same_JJ
        vacuoles_NNS (_( Fig_NNP ._. 7_CD )_) ._. Finally_RB ,_, catalase_NN signal_NN is_VBZ also_RB
        detected_VBN in_IN both_DT small_JJ and_CC large_JJ ,_, SOD_NNP 1_CD -_: positive_JJ vacuoles_NNS at_IN
        early_JJ disease_NN stages_NNS (_( Fig_NNP ._. 8_CD )_) ._. These_DT results_NNS suggest_VBP that_IN
        peroxisomes_NNS actively_RB participate_VBP in_IN the_DT formation_NN of_IN
        mitochondrial_NN vacuoles_NNS at_IN the_DT early_JJ stages_NNS ._.
        Because_IN lysosomes_NNS participate_VBP in_IN autophagy_NN [_NN 30_CD ]_NN ,_, we_PRP
        examined_VBD whether_IN lysosomes_NNS participate_VBP in_IN vacuole_NN
        formation_NN ._. We_PRP doubly_RB stained_JJ spinal_JJ cord_NN sections_NNS with_IN
        antibodies_NNS against_IN SOD_NNP 1_CD and_CC cathepsin_NN D_NNP ,_, a_DT lysosomal_NN
        protease_NN ._. Vacuoles_NNP do_VBP not_RB contain_VB high_JJ levels_NNS of_IN cathepsin_NN
        D_NNP signal_NN (_( Fig_NNP ._. 9_CD )_) ._. For_IN example_NN ,_, the_DT vacuole_NN in_IN figure_NN
        9_CD Bcontains_NNP no_DT more_JJR cathepsin_NN D_NNP signal_NN than_IN a_DT normal_JJ motor_NN
        neuron_NN cell_NN body_NN in_IN figure_NN 9_CD F_NN ._. Noticeably_NNP ,_, no_DT cathepsin_NN D_NNP
        signal_NN is_VBZ associated_VBN with_IN small_JJ vacuoles_NNS (_( Fig_NNP ._. 9_CD E_NNP ,_, 9_CD F_NN ,_, 9_CD G_NNP ,_, 9_CD H_NNP ,_,
        arrows_NNS )_) ._. These_DT results_NNS indicate_VBP that_IN lysosomes_NNS do_VBP not_RB
        actively_RB participate_VB in_IN vacuole_NN formation_NN ._.
        The_DT absence_NN of_IN matrix_NN expansion_NN and_CC the_DT involvement_NN of_IN
        peroxisomes_NNS but_CC not_RB lysosomes_NNS together_RB indicate_VBP that_IN mutant_JJ
        SOD_NNP 1_CD -_: induced_VBN mitochondrial_NN vacuolation_NN is_VBZ neither_DT MPT_NNP nor_CC
        autophagy_NN ._. Because_IN mutant_JJ SOD_NNP 1_CD is_VBZ prone_JJ to_TO unfold_VB [_NN 31_CD 32_CD
        33_CD 34_CD ]_NN and_CC form_NN aggregates_NNS [_NN 11_CD 14_CD 35_CD 36_CD ]_NN ,_, it_PRP has_VBZ been_VBN
        proposed_VBN that_IN abnormal_JJ SOD_NNP 1_CD aggregation_NN generates_VBZ toxicity_NN
        [_NN 10_CD ]_NN ._. To_TO determine_VB whether_IN SOD_NNP 1_CD aggregates_NNS are_VBP involved_VBN
        in_IN mitochondrial_NN vacuolation_NN ,_, we_PRP examined_VBD whether_IN vacuoles_NNS
        contain_VBP SOD_NNP 1_CD aggregates_NNS by_IN immunofluorescence_NN and_CC immuno_NN
        EM_NNP ._. SOD_NNP 1_CD aggregates_NNS are_VBP in_IN the_DT majority_NN of_IN vacuoles_NNS (_( Fig_NNP ._.
        10_CD ;_: also_RB see_VB figures_NNS 2_CD ,_, 3_CD ,_, 5_CD ,_, 6_CD and_CC 9_CD ,_, arrowheads_NNS )_) ._. In_IN all_DT
        cases_NNS ,_, the_DT aggregates_NNS were_VBD found_VBN to_TO be_VB on_IN or_CC near_IN the_DT
        boundary_NN of_IN the_DT vacuoles_NNS (_( Fig_NNP ._. 10_CD ,_, arrowheads_NNS )_) ._. Some_DT SOD_NNP 1_CD
        aggregates_NNS overlap_VBP with_IN CO_NNP 1_CD signal_NN while_IN others_NNS do_VBP not_RB (_( see_VB
        Fig_NNP ._. 2_LS Aand_NNP 2_CD B_NNP )_) ._. In_IN small_JJ vacuoles_NNS ,_, SOD_NNP 1_CD aggregates_NNS overlap_VBP
        with_IN cytochrome_NN c_SYM signal_NN (_( see_VB Fig_NNP ._. 5_LS E_NNP ,_, 5_CD F_NN ,_, 5_CD G_NNP )_) ._. These_DT results_NNS
        suggest_VBP a_DT role_NN of_IN mutant_JJ SOD_NNP 1_CD aggregation_NN in_IN 
        
          M_NNP 
         itochondrial_NN 
        
          V_NNP 
         acuolation_NN by_IN 
        
          I_PRP 
         ntermembrane_NN 
        
          S_NNP 
         pace_NN 
        
          E_NN 
         xpansion_NN (_( 
        MVISE_NNP )_) ._.
      
      
        Discussion_NNP
        Our_PRP$ EM_NNP observations_NNS (_( Fig_NNP ._. 1_LS )_) suggest_VBP that_IN mutant_JJ SOD_NNP 1_CD
        G_NNP 93_CD Acauses_NNP MVISE_NNP in_IN vivo_NN ._. These_DT observations_NNS agree_VBP with_IN an_DT
        earlier_JJR suggestion_NN that_IN vacuoles_NNS in_IN the_DT SOD_NNP 1_CD G_NNP 93_CD Amouse_NNP
        model_NN of_IN ALS_NNP are_VBP derived_VBN from_IN the_DT expansion_NN of_IN
        mitochondrial_NN intermembrane_NN space_NN [_NN 17_CD ]_NN ._. Our_PRP$ subsequent_JJ
        experiments_NNS confirm_VBP this_DT model_NN ._. First_LS ,_, the_DT inner_JJ
        mitochondrial_NN membrane_NN does_VBZ not_RB constitute_VB the_DT vacuole_NN
        boundary_NN and_CC is_VBZ contained_VBN within_IN the_DT vacuoles_NNS (_( Fig_NNP ._. 2_LS )_) ._.
        Second_JJ ,_, the_DT outer_JJ mitochondrial_NN membrane_NN composes_NNS a_DT large_JJ
        part_NN of_IN the_DT vacuolar_NN membrane_NN (_( Figs_NNP ._. 3_LS ,_, 4_LS )_) ._. Third_NNP ,_,
        cytochrome_NN c_SYM colocalizes_NNS with_IN SOD_NNP 1_CD in_IN small_JJ vacuoles_NNS ._. Both_DT
        molecules_NNS are_VBP known_VBN intermembrane_NN space_NN proteins_NNS ._. Although_IN
        cytochrome_NN c_SYM signal_NN is_VBZ lost_VBN in_IN the_DT subsequent_JJ vacuolar_NN
        expansion_NN (_( Fig_NNP ._. 5_LS )_) ,_, this_DT absence_NN could_MD be_VB due_JJ to_TO a_DT dilution_NN
        of_IN cytochrome_NN c_SYM by_IN the_DT increased_VBN vacuolar_NN volume_NN [_NN 17_CD ]_NN and_CC
        leakage_NN of_IN the_DT outer_JJ mitochondrial_NN membrane_NN ._. Fourth_JJ ,_,
        catalase-_NN and_CC PMP_NNP 70_CD -_: positive_JJ granules_NNS are_VBP concentrated_VBN in_IN
        the_DT vacuoles_NNS (_( Fig_NNP ._. 6_CD ,_, 7_CD ,_, 8_CD )_) but_CC lysosomes_NNS are_VBP not_RB (_( Fig_NNP ._. 9_CD )_) ._.
        This_DT suggests_VBZ that_IN peroxisomes_NNS actively_RB participate_VBP in_IN the_DT
        vacuole_NN formation_NN but_CC lysosomes_NNS do_VBP not_RB play_VB a_DT significant_JJ
        role_NN ._. These_DT observations_NNS indicate_VBP that_IN neither_DT MPT_NNP
        (_( expansion_NN of_IN matrix_NN )_) nor_CC autophagy_NN (_( in_IN which_WDT lysosomes_NNS
        participate_VBP )_) is_VBZ responsible_JJ for_IN mutant_JJ SOD_NNP 1_CD -_: induced_VBN
        mitochondrial_NN vacuolation_NN ._. Thus_RB ,_, MVISE_NNP represents_VBZ a_DT
        previously_RB uncharacterized_JJ mechanism_NN of_IN mitochondrial_NN
        degeneration_NN in_IN the_DT CNS_NNP ._.
        How_WRB mutant_JJ SOD_NNP 1_CD causes_NNS MVISE_NNP is_VBZ not_RB known_VBN but_CC could_MD be_VB
        associated_VBN with_IN SOD_NNP 1_CD localization_NN ._. Fridovich_NNP and_CC colleagues_NNS
        first_RB noticed_VBD the_DT presence_NN of_IN SOD_NNP 1_CD in_IN the_DT intermembrane_NN
        space_NN in_IN liver_NN mitochondria_NN [_NN 37_CD ]_NN ._. Although_IN this_DT was_VBD
        disputed_VBN later_RB [_NN 38_CD 39_CD ]_NN ,_, recent_JJ experiments_NNS in_IN yeast_NN and_CC
        mammalian_JJ cells_NNS reaffirmed_VBD the_DT presence_NN of_IN both_DT wild_JJ type_NN
        and_CC mutant_JJ SOD_NNP 1_CD in_IN the_DT intermembrane_NN space_NN of_IN mitochondria_NN
        [_NN 21_CD 25_CD 26_CD 40_CD ]_NN ._. This_DT finding_VBG suggests_VBZ that_IN mutant_JJ SOD_NNP 1_CD
        could_MD directly_RB damage_VB mitochondria_NN by_IN its_PRP$ toxicity_NN ._. The_DT
        increased_VBN cell_NN death_NN induced_VBN by_IN direct_JJ targeting_VBG of_IN mutant_JJ
        SOD_NNP 1_CD to_TO mitochondria_NN supports_VBZ this_DT possibility_NN [_NN 27_CD ]_NN ._.
        Interestingly_RB ,_, low_JJ levels_NNS (_( compared_VBN with_IN the_DT levels_NNS caused_VBN
        by_IN mutant_JJ SOD_NNP 1_LS )_) of_IN mitochondrial_NN vacuolation_NN can_MD also_RB be_VB
        caused_VBN by_IN expression_NN of_IN high_JJ levels_NNS of_IN wild_JJ type_NN SOD_NNP 1_CD [_NN 7_CD
        13_CD 15_CD 41_CD ]_NN ,_, suggesting_VBG that_IN the_DT mitochondria-damaging_JJ
        property_NN also_RB exists_VBZ in_IN the_DT wild_JJ type_NN protein_NN and_CC this_DT
        property_NN strengthens_VBZ by_IN the_DT mutations_NNS ._.
        The_DT toxicity_NN produced_VBN by_IN mutant_JJ SOD_NNP 1_CD that_WDT leads_VBZ to_TO
        mitochondrial_NN damage_NN remains_VBZ to_TO be_VB identified_VBN ._. One_CD
        possibility_NN is_VBZ that_IN mutant_JJ SOD_NNP 1_CD catalyzes_NNS abnormal_JJ redox_NN
        reactions_NNS ,_, thereby_RB producing_VBG toxic_JJ reactive_JJ oxygen_NN species_NNS
        (_( ROS_NNP )_) and_CC damaging_JJ cellular_JJ structures_NNS in_IN its_PRP$ vicinity_NN ._. Two_CD
        such_JJ activities_NNS have_VBP been_VBN proposed_VBN ._. The_DT first_JJ proposes_VBZ that_IN
        the_DT mutated_VBN SOD_NNP 1_CD interacts_NNS with_IN NO_DT to_TO produce_NN peroxynitrite_NN
        (_( ONOO_NNP -_: )_) ,_, which_WDT damages_VBZ proteins_NNS by_IN modifying_VBG tyrosine_NN to_TO
        nitrotyrosine_NN residues_NNS [_NN 42_CD 43_CD 44_CD ]_NN ._. The_DT second_JJ postulates_NNS
        that_IN the_DT mutant_JJ SOD_NNP 1_CD possesses_VBZ an_DT enhanced_JJ peroxidase_NN
        activity_NN ,_, which_WDT causes_VBZ oxidative_JJ modification_NN of_IN nucleic_JJ
        acids_NNS ,_, proteins_NNS and_CC lipids_NNS [_NN 45_CD 46_CD 47_CD ]_NN ._. Both_DT of_IN these_DT
        activities_NNS require_VBP copper_NN at_IN the_DT active_JJ center_NN of_IN SOD_NNP 1_CD ._.
        However_RB ,_, dramatic_JJ reduction_NN of_IN copper_NN in_IN SOD_NNP 1_CD by_IN knocking_VBG
        out_RP the_DT copper_NN chaperon_NN for_IN SOD_NNP 1_CD (_( CCS_NNP )_) ,_, or_CC by_IN mutating_VBG the_DT
        copper_NN chelating_VBG residues_NNS ,_, did_VBD not_RB affect_VB ALS_NNP progression_NN
        in_IN vivo_NN [_NN 36_CD 48_CD ]_NN ._. Therefore_RB ,_, the_DT role_NN of_IN copper-mediated_JJ
        oxidative_JJ damage_NN remains_VBZ unclear_JJ [_NN 49_CD 50_CD ]_NN ._.
        An_DT alternative_JJ proposal_NN is_VBZ that_IN the_DT toxicity_NN stems_VBZ from_IN
        the_DT propensity_NN of_IN the_DT mutated_VBN SOD_NNP 1_CD to_TO aggregate_JJ ._. SOD_NNP 1_CD
        aggregates_NNS have_VBP been_VBN widely_RB observed_VBN in_IN mutant_JJ SOD_NNP 1_CD
        transgenic_JJ mice_NNS and_CC in_IN human_JJ ALS_NNP caused_VBN by_IN SOD_NNP 1_CD mutations_NNS [_NN
        11_CD 14_CD 35_CD 36_CD ]_NN ._. In_IN cultured_JJ cells_NNS ,_, mutant_JJ SOD_NNP 1_CD forms_NNS high_JJ
        molecular_JJ weight_NN aggregates_NNS when_WRB the_DT cells_NNS are_VBP stressed_VBN by_IN
        high_JJ mutant_JJ protein_NN expression_NN [_NN 51_CD ]_NN ,_, proteosome_NN
        inhibition_NN [_NN 52_CD ]_NN and_CC serum_NN withdraw_VB [_NN 27_CD ]_NN ._. The_DT role_NN of_IN
        mutant_JJ SOD_NNP 1_CD aggregation_NN ,_, however_RB ,_, remains_VBZ unclear_JJ ._. One_CD
        study_NN reports_NNS that_IN SOD_NNP 1_CD aggregation_NN and_CC cell_NN death_NN
        stimulating_VBG activity_NN are_VBP dissociable_JJ in_IN mutant_JJ
        SOD_NNP 1_CD -_: transfected_JJ PC_NN 12_CD cells_NNS [_NN 53_CD ]_NN ._.
        All_DT studies_NNS conducted_VBN on_IN SOD_NNP 1_CD aggregation_NN thus_RB far_RB have_VBP
        been_VBN on_IN the_DT large_JJ aggregates_NNS that_WDT might_MD be_VB composed_VBN of_IN long_JJ
        fibrils_NNS ._. The_DT role_NN of_IN small_JJ ,_, oligomeric_JJ SOD_NNP 1_CD aggregation_NN has_VBZ
        not_RB been_VBN investigated_VBN ._. Recent_JJ studies_NNS on_IN neurodegenerative_JJ
        diseases_NNS ,_, including_VBG Parkinson_NNP 's_POS ,_, Alzheimer_NNP 's_POS and_CC prion_NN
        diseases_NNS ,_, suggest_VBP that_IN it_PRP is_VBZ not_RB the_DT long_JJ fibrils_NNS that_WDT
        produce_VBP toxicity_NN and_CC kill_VB neurons_NNS ,_, rather_RB ,_, it_PRP is_VBZ the_DT
        oligomeric_JJ aggregation_NN intermediates_NNS that_WDT produce_VBP toxicity_NN
        [_NN 54_CD 55_CD ]_NN ._. Interestingly_RB ,_, interactions_NNS between_IN
        biomembranes_NNS and_CC toxic_JJ proteins_NNS produce_VBP a_DT dual_JJ effect_NN of_IN
        both_DT promoting_VBG oligomeric_JJ aggregation_NN of_IN the_DT proteins_NNS and_CC
        membrane_NN damage_NN [_NN 56_CD 57_CD 58_CD 59_CD ]_NN ,_, suggesting_VBG that_IN one_CD
        possible_JJ toxicity_NN of_IN oligomeric_JJ aggregates_NNS is_VBZ mediated_JJ
        through_IN damaging_JJ membranes_NNS ._. In_IN this_DT context_NN ,_, our_PRP$
        observation_NN that_IN SOD_NNP 1_CD aggregates_NNS are_VBP associated_VBN with_IN
        vacuolar_NN membrane_NN (_( Figs_NNP ._. 2_LS ,_, 10_CD )_) suggests_VBZ that_IN mutant_JJ SOD_NNP 1_CD
        interacts_NNS with_IN mitochondrial_NN membrane_NN and_CC this_DT interaction_NN
        promotes_VBZ aggregation_NN ._. The_DT form_NN of_IN these_DT aggregates_NNS is_VBZ not_RB
        yet_RB known_VBN but_CC could_MD include_VB both_DT the_DT large_JJ aggregates_NNS (_( e_SYM ._. g_SYM ._.
        Fig_NNP ._. 10_CD ,_, arrowheads_NNS )_) that_DT bind_NN to_TO thioflavin_NN S_NNP [_NN 36_CD ]_NN ,_, and_CC
        oligomers_NNS ,_, which_WDT may_MD be_VB represented_VBN by_IN the_DT intense_JJ SOD_NNP 1_CD
        immuno-reactive_JJ signals_NNS associated_VBN with_IN vacuolar_NN membrane_NN
        (_( Fig_NNP ._. 10_CD )_) ._.
        The_DT presence_NN of_IN peroxisomes_NNS in_IN mutant_JJ SOD_NNP 1_CD -_: induced_VBN MVISE_NNP
        is_VBZ a_DT surprise_NN ._. How_WRB this_DT occurs_VBZ is_VBZ unclear_JJ ._. Nevertheless_RB ,_,
        the_DT higher_JJR concentration_NN of_IN peroxisomes_NNS in_IN and_CC around_IN
        vacuoles_NNS suggests_VBZ that_IN peroxisomes_NNS actively_RB migrate_VB to_TO or_CC
        proliferate_VBP in_IN the_DT vicinity_NN of_IN abnormal_JJ mitochondria_NN and_CC
        participate_VB in_IN the_DT vacuolation_NN process_NN ._. What_WP might_MD be_VB the_DT
        role_NN of_IN peroxisome_NN ?_. The_DT answer_NN is_VBZ not_RB known_VBN but_CC the_DT normal_JJ
        peroxisome_NN function_NN might_MD provide_VB some_DT clues_NNS ._. Peroxisomes_NNP
        are_VBP indispensable_JJ in_IN lipid_NN metabolism_NN and_CC maintenance_NN of_IN
        lipid_NN homeostasis_NNS ._. Peroxisomes_NNP shorten_VB chains_NNS of_IN very_RB long_JJ
        fatty_NN acids_NNS ,_, unsaturated_JJ fatty_NN acids_NNS and_CC branched_VBN fatty_NN
        acids_NNS by_IN β-oxidation_JJ [_NN 60_CD 61_CD ]_NN ._. They_PRP play_VBP critical_JJ roles_NNS
        in_IN synthesis_NN of_IN ether_NN phospholipids_NNS and_CC cholesterol_NN [_NN 62_CD 63_CD
        ]_NN ._. Peroxisomal_NNP abundance_NN is_VBZ associated_VBN with_IN high_JJ membrane_NN
        demand_NN such_JJ as_IN myelination_NN in_IN the_DT central_JJ nervous_JJ system_NN [_NN
        64_CD 65_CD ]_NN and_CC peroxisome_NN diseases_NNS result_VBP in_IN defective_JJ
        myelination_NN [_NN 66_CD ]_NN ._. Because_IN the_DT outer_JJ mitochondrial_NN
        membrane_NN normally_RB tightly_RB wraps_VBZ around_IN mitochondria_NN ,_, the_DT
        extension_NN of_IN the_DT outer_JJ membrane_NN during_IN vacuolation_NN requires_VBZ
        new_JJ membranes_NNS ._. Peroxisomes_NNP could_MD provide_VB the_DT new_JJ membranes_NNS
        by_IN either_DT synthesis_NN of_IN lipids_NNS or_CC fusing_NN themselves_PRP with_IN the_DT
        vacuolar_NN membrane_NN ._. Alternatively_RB ,_, peroxisomes_NNS might_MD be_VB
        involved_VBN in_IN membrane_NN breakdown_NN in_IN the_DT mitochondrial_NN
        degeneration_NN process_NN ._. Interestingly_RB ,_, accumulation_NN of_IN
        ceramides_NNS and_CC cholesterol_NN esters_NNS has_VBZ been_VBN observed_VBN in_IN ALS_NNP
        patients_NNS and_CC mice_NNS [_NN 67_CD ]_NN ,_, which_WDT could_MD be_VB associated_VBN with_IN
        peroxisomal_NN proliferation_NN ._.
        The_DT mitochondrial_NN vacuolation_NN could_MD in_IN part_VB be_VBP the_DT
        result_NN of_IN persistent_JJ mitochondrial_NN dysfunction_NN and_CC further_JJ
        facilitate_VB the_DT downstream_JJ motor_NN neuron_NN degeneration_NN events_NNS ._.
        Our_PRP$ previous_JJ study_NN showed_VBD that_IN functional_JJ decline_NN of_IN
        mitochondria_NN appears_VBZ in_IN the_DT SOD_NNP 1_CD G_NNP 93_CD Amice_NNP as_RB early_RB as_IN 60_CD to_TO
        100_CD days_NNS of_IN age_NN [_NN 22_CD ]_NN ._. This_DT precedes_VBZ the_DT peak_NN of_IN
        mitochondrial_NN vacuolation_NN and_CC the_DT onset_NN of_IN the_DT disease_NN by_IN
        two_CD to_TO three_CD months_NNS [_NN 15_CD ]_NN ._. Mitochondrial_NNP dysfunction_NN can_MD
        lead_VB to_TO energy_NN deficiency_NN and_CC ionic_JJ imbalance_NN [_NN 68_CD ]_NN ,_,
        elevated_VBD ROS_NNP and_CC oxidative_JJ damage_NN [_NN 69_CD ]_NN ,_, and_CC increased_VBN
        sensitivity_NN of_IN neurons_NNS to_TO excitotoxicity_NN [_NN 19_CD 70_CD 71_CD 72_CD ]_NN ._.
        These_DT effects_NNS could_MD precipitate_NN MVISE_NNP ,_, which_WDT trigger_VBP cell_NN
        death_NN programs_NNS by_IN releasing_VBG pro-apoptotic_JJ proteins_NNS resided_VBN
        in_IN the_DT mitochondrial_NN intermembrane_NN space_NN ,_, such_JJ as_IN
        cytochrome_NN c_SYM ,_, AIF_NNP ,_, SMAC_NNP /_NN DIABLO_NNP ,_, endo_NN G_NNP and_CC Htra_NNP /_NN Omi_NNP [_NN 73_CD ]_NN
        ._. The_DT absence_NN of_IN cytochrome_NN c_SYM in_IN the_DT porous_JJ large_JJ vacuoles_NNS
        and_CC the_DT presence_NN of_IN cytochrome_NN c_SYM in_IN the_DT small_JJ vacuoles_NNS
        (_( Fig_NNP ._. 5_LS )_) are_VBP consistent_JJ with_IN this_DT possibility_NN ._. Because_IN the_DT
        majority_NN of_IN vacuoles_NNS develop_VBP in_IN distal_NN small_JJ dendrites_NNS [_NN 28_CD
        ]_NN ,_, the_DT release_NN of_IN these_DT proapoptotic_JJ molecules_NNS may_MD not_RB
        cause_VB typical_JJ apoptotic_JJ changes_NNS in_IN cell_NN bodies_NNS including_VBG
        chromatin_NN condensation_NN and_CC cytoplasmic_JJ blebbing_VBG ._. Indeed_RB ,_,
        the_DT typical_JJ changes_NNS are_VBP not_RB observed_VBN by_IN EM_NNP (_( Higgins_NNP ,_, Kong_NNP
        and_CC Xu_NNP ,_, unpublished_JJ observation_NN ;_: also_RB see_VB [_NN 74_CD 75_CD ]_NN )_) ,_, but_CC
        widespread_JJ caspase_NN activation_NN is_VBZ detected_VBN in_IN spinal_JJ cords_NNS [_NN
        75_CD 76_CD 77_CD ]_NN ,_, suggesting_VBG the_DT occurrence_NN of_IN a_DT neuritic_JJ death_NN
        program_NN [_NN 78_CD ]_NN ._.
        Our_PRP$ results_NNS as_RB well_RB as_IN others_NNS '_POS show_NN that_DT mitochondrial_NN
        vacuolation_NN provides_VBZ an_DT important_JJ window_NN for_IN examination_NN of_IN
        the_DT mechanism_NN whereby_WRB mutant_JJ SOD_NNP 1_CD causes_NNS mitochondrial_NN
        damage_NN and_CC motor_NN neuron_NN degeneration_NN ._. However_RB ,_, some_DT mutant_JJ
        SOD_NNP 1_CD causes_NNS motor_NN neuron_NN degeneration_NN without_IN mitochondrial_NN
        vacuolation_NN [_NN 8_CD 11_CD 36_CD ]_NN ._. One_CD difference_NN between_IN the_DT
        mutants_NNS that_WDT induce_VB vacuoles_NNS and_CC the_DT ones_NNS that_WDT do_VBP not_RB ,_, is_VBZ
        that_IN the_DT former_JJ accumulates_NNS at_IN higher_JJR levels_NNS in_IN the_DT mouse_NN
        spinal_JJ cord_NN than_IN that_DT latter_NN ._. It_PRP is_VBZ possible_JJ that_DT
        mitochondrial_NN vacuolation_NN represents_VBZ an_DT accelerated_VBN form_NN of_IN
        mitochondrial_NN damage_NN caused_VBN by_IN high_JJ levels_NNS of_IN mutant_JJ SOD_NNP 1_CD
        accumulation_NN ._. This_DT does_VBZ present_VB a_DT challenge_NN to_TO examine_VB and_CC
        define_VB mitochondrial_NN damage_NN in_IN low_JJ mutant_JJ SOD_NNP 1_CD expressing_VBG
        transgenic_JJ lines_NNS ._.
      
      
        Conclusions_NNP
        Taken_VBN together_RB ,_, this_DT study_NN reveals_VBZ a_DT mitochondrial_NN
        degeneration_NN mechanism_NN in_IN the_DT CNS_NNP ,_, mitochondrial_NN
        vacuolation_NN by_IN intermembrane_NN space_NN expansion_NN or_CC MVISE_NNP ._. The_DT
        basic_JJ features_NNS of_IN MVISE_NNP are_VBP expansion_NN of_IN mitochondrial_NN
        intermembrane_NN space_NN ,_, extension_NN of_IN mitochondrial_NN outer_JJ
        membrane_NN ,_, collapse_NN and_CC /_NN or_CC disintegration_NN of_IN the_DT matrix_NN and_CC
        inner_JJ membrane_NN ,_, and_CC involvement_NN of_IN peroxisomes_NNS ._. These_DT
        features_VBZ bare_JJ resemblances_NNS to_TO mitochondrial_NN degeneration_NN in_IN
        other_JJ neurodegenerative_JJ conditions_NNS ,_, including_VBG Alzheimer_NNP 's_POS
        disease_NN [_NN 79_CD ]_NN ,_, prion_NN disease_NN [_NN 80_CD ]_NN ,_, Rett_NNP syndrome_NN [_NN 81_CD
        ]_NN ,_, excitotoxic_JJ neuronal_NN death_NN [_NN 70_CD ]_NN and_CC Mn_NNP +_NN +_NN superoxide_NN
        dismutase_NN (_( SOD_NNP 2_LS )_) deletion_NN [_NN 82_CD ]_NN ._. Although_IN in_IN none_NN of_IN
        these_DT conditions_NNS are_VBP sufficiently_RB detailed_JJ observations_NNS
        available_JJ for_IN a_DT comprehensive_JJ comparison_NN ,_, MVISE_NNP could_MD play_VB
        a_DT role_NN in_IN other_JJ neurodegenerative_JJ disorders_NNS ._. Mitochondrial_NNP
        vacuolation_NN may_MD contribute_VB to_TO several_JJ non-apopototic_JJ cell_NN
        death_NN pathways_NNS ,_, but_CC its_PRP$ role_NN in_IN a_DT wide_JJ spectrum_NN of_IN
        neurodegenerative_JJ diseases_NNS remains_VBZ to_TO be_VB defined_VBN [_NN 83_CD 84_CD ]_NN
        ._.
      
      
        Methods_NNP
        
          Transgenic_NNP mice_NNS
          The_DT low_JJ expression_NN line_NN of_IN transgenic_JJ mice_NNS expressing_VBG
          human_JJ mutant_JJ SOD_NNP 1_CD G_NNP 93_CD A_DT (_( C_NNP 57_CD BL_NNP /_NN 6_CD J-T_NNP gN_NN (_( SOD_NNP 1_CD -_: G_NNP 93_CD A_DT )_) 1_CD Gur_NNP dl_NN )_)
          were_VBD purchased_VBN from_IN Jackson_NNP Lab_NNP (_( Bar_NNP Harbor_NNP ,_, ME_NNP )_) and_CC bred_VBN
          onto_IN FVB_NNP background_NN at_IN University_NNP of_IN Massachusetts_NNP
          Medical_NNP School_NNP animal_NN facility_NN ._. Non-transgenic_NNP
          littermates_NNS of_IN SOD_NNP G_NNP 93_CD Atransgenic_NNP mice_NNS were_VBD used_VBN as_IN wild_JJ
          type_NN controls_NNS (_( WT_NNP mice_NNS )_) ._. All_DT transgenic_JJ mice_NNS were_VBD
          identified_VBN using_VBG PCR_NNP according_VBG to_TO Gurney_NNP et_CC al_NN ._. [_NN 85_CD ]_NN ._.
          Mice_NNS were_VBD maintained_VBN at_IN the_DT University_NNP of_IN Massachusetts_NNP
          Medical_NNP School_NNP animal_NN facility_NN according_VBG to_TO the_DT
          guidelines_NNS set_VBN forth_RB by_IN the_DT Institutional_NNP Animal_NNP Care_NNP and_CC
          Use_NNP Committee_NNP (_( IACUC_NNP )_) ._.
        
        
          Immunofluorescence_NNP Microscopy_NNP
          Mice_NNS were_VBD perfused_JJ under_IN anesthesia_NN with_IN fixative_JJ (_( 4_CD %_NN
          paraformaldehyde_NN ,_, 0_CD ._. 1_CD %_NN glutaraldehyde_NN in_IN 0_CD ._. 1_CD M_NNP phosphate_NN
          buffer_NN ,_, pH_NN 7_CD ._. 5_LS )_) ._. Sections_NNP of_IN lumbar_NN spinal_JJ cords_NNS from_IN
          fixed_VBN mice_NNS were_VBD dissected_VBN out_IN and_CC 30_CD μm_NN sections_NNS were_VBD cut_VBN
          using_VBG a_DT vibratome_NN ._. Sections_NNP were_VBD processed_VBN for_IN antibody_NN
          staining_VBG using_VBG the_DT following_JJ antibodies_NNS :_: rabbit_NN [_NN 86_CD ]_NN
          and_CC sheep_NN (_( BioDesign_NNP )_) anti-_NN SOD_NNP 1_CD (_( both_DT recognize_VB mouse_NN and_CC
          human_JJ SOD_NNP 1_LS )_) ,_, mouse_NN anti-cytochrome_JJ c_SYM oxidase_NN subunit_NN CO_NNP 1_CD
          and_CC CO_NNP 4_CD (_( Molecular_NNP Probes_NNP ,_, OR_NNP )_) ,_, rabbit_NN anti-_NN TOM_NNP 20_CD and_CC
          TOM_NNP 40_CD (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_, CA_NNP )_) ,_, mouse_NN
          anti-cytochrome_JJ c_SYM (_( BD_NNP PharMingen_NNP ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ,_, sheep_NN
          anti-catalase_JJ (_( The_DT Binding_NNP Site_NNP ,_, Birmingham_NNP ,_, England_NNP )_) ,_,
          rabbit_NN anti-catalase_JJ (_( Calbiochem_NNP ,_, SanDiego_NNP ,_, CA_NNP )_) ,_, rabbit_NN
          anti-_NN PMP_NNP 70_CD (_( ABR_NNP ,_, Golden_NNP ,_, CO_NNP or_CC Axxora_NNP ,_, SanDiego_NNP ,_, CA_NNP )_) ,_, and_CC
          rabbit_NN anti-cathepsin_JJ D_NNP (_( DAKO_NNP ,_, Carpinteria_NNP ,_, CA_NNP )_) according_VBG
          to_TO the_DT protocol_NN described_VBD previously_RB [_NN 26_CD 28_CD ]_NN ._. The_DT
          stained_JJ sections_NNS were_VBD examined_VBN and_CC digitized_JJ using_VBG a_DT
          confocal_NN microscope_NN (_( Leica_NNP TCS-SP_NNP )_) ._. Imaging_NNP analysis_NN and_CC
          three-dimensional_JJ reconstruction_NN were_VBD conducted_VBN using_VBG
          MetaMorph_NNP (_( Universal_NNP Imaging_NNP Corp_NNP ._. )_) ._.
        
        
          Transmission_NNP electron_NN microscopy_NN (_( TEM_NNP )_)
          Animal_NNP fixation_NN ,_, tissue_NN dissection_NN ,_, and_CC microscopic_JJ
          analysis_NN were_VBD performed_VBN as_IN described_VBN previously_RB [_NN 15_CD ]_NN ._.
          In_IN brief_JJ ,_, mice_NNS were_VBD anesthetized_JJ and_CC perfused_JJ with_IN a_DT
          solution_NN of_IN 4_CD %_NN paraformaldehyde_NN and_CC 2_CD ._. 5_CD %_NN glutaraldehyde_NN
          in_IN 0_CD ._. 1_CD M_NNP phosphate_NN buffer_NN ,_, pH_NN 7_CD ._. 6_CD ._. Tissues_NNPS were_VBD kept_VBN in_IN
          the_DT same_JJ solution_NN for_IN further_JJ fixation_NN ._. The_DT L_NNP 4_CD and_CC L_NNP 5_CD
          spinal_JJ nerve_NN roots_NNS and_CC lumbar_NN spinal_JJ cords_NNS (_( a_DT 2_CD mm_NN
          segment_NN centered_VBN at_IN the_DT L_NNP 5_CD root_NN entry_NN level_NN )_) were_VBD
          dissected_VBN out_IN and_CC post-fixed_JJ with_IN 2_CD %_NN osmium_NN tetroxide_NN in_IN
          100_CD mM_NN cacodylate_NN buffer_NN ,_, pH_NN 7_CD ._. 6_CD ._. After_IN dehydration_NN in_IN
          graded_JJ alcohol_NN ,_, the_DT tissue_NN blocks_NNS were_VBD embedded_VBN in_IN Epon_NNP ._.
          Thin_JJ sections_NNS of_IN ventral_NN horn_NN were_VBD cut_VBN from_IN the_DT Epon_NNP
          tissue_NN blocks_NNS ,_, stained_JJ with_IN uranyl_NN acetate_NN and_CC lead_VB
          citrate_NN ,_, and_CC visualized_JJ using_VBG a_DT Philips_NNP CM_NNP 10_CD transmission_NN
          electron_NN microscope_NN ._.
        
        
          Immuno-electron_NNP microscopy_NN
          Mice_NNS were_VBD perfused_JJ under_IN anesthesia_NN with_IN fixative_JJ (_( 4_CD %_NN
          paraformaldehyde_NN ,_, 0_CD ._. 1_CD %_NN glutaraldehyde_NN in_IN 0_CD ._. 1_CD M_NNP phosphate_NN
          buffer_NN ,_, pH_NN 7_CD ._. 5_LS )_) ._. Sections_NNP of_IN lumbar_NN spinal_JJ cords_NNS from_IN
          fixed_VBN mice_NNS were_VBD dissected_VBN out_IN ,_, dehydrated_JJ through_IN an_DT
          ethanol_NN series_NN to_TO 100_CD %_NN ethanol_NN and_CC embedded_VBN in_IN hard_JJ grade_NN
          LR_NNP White_NNP resin_NN (_( EMS_NNP ,_, Fort_NNP Washington_NNP ,_, PA_NNP )_) by_IN
          polymerization_NN overnight_JJ at_IN 60_CD deg_NN ._. C_NNP ._. Sixty_CD five_CD nm_NN
          sections_NNS were_VBD cut_VBN from_IN the_DT embedded_VBN tissue_NN using_VBG a_DT
          Reichert-_NNP Jung_NNP Ultracut_NNP E_NNP microtome_NN and_CC collected_VBN onto_IN
          gold_JJ grids_NNS (_( 200_CD mesh_VB )_) (_( SPI_NNP Inc_NNP ._. ,_, Westchester_NNP ,_, PA_NNP )_) ._.
          Sections_NNP on_IN grids_NNS were_VBD processed_VBN for_IN immunogold_NN electron_NN
          microscopy_NN according_VBG to_TO recommendations_NNS by_IN the_DT
          manufacturer_NN of_IN the_DT gold-conjugated_JJ antibodies_NNS (_( Amersham_NNP
          Pharmacia_NNP Biotech_NNP ,_, Piscataway_NNP ,_, NJ_NNP )_) with_IN some_DT
          modification_NN ._. Sections_NNP were_VBD etched_JJ in_IN 0_CD ._. 1_CD N_NNP HCl_NNP for_IN 5_CD
          min_NN ._. ,_, rinsed_JJ three_CD times_NNS for_IN five_CD min_NN each_DT in_IN TBS_NNP (_( 25_CD mM_NN
          Tris_NNP ,_, 140_CD mM_NN NaCl_NNP ,_, 2_CD ._. 7_CD mM_NN KCl_NNP ,_, pH_NN 8_CD ._. 0_CD )_) ,_, placed_VBN in_IN
          blocking_VBG buffer_NN for_IN 30_CD min_NN (_( 0_CD ._. 1_LS %_NN gelatin_NN ,_, 1_CD %_NN normal_JJ goat_NN
          serum_NN ,_, 0_CD ._. 3_CD %_NN Triton-_NNP X-_NNP 100_CD in_IN TBS_NNP )_) ,_, placed_VBN in_IN primary_JJ
          antibody_NN (_( 1_CD :_: 10_CD diluted_VBN in_IN blocking_VBG buffer_NN for_IN all_DT
          antibodies_NNS used_VBN )_) for_IN 2_CD hours_NNS at_IN room_NN temperature_NN ,_, rinsed_JJ
          3_CD times_NNS for_IN 5_CD min_NN each_DT in_IN TBS_NNP ,_, placed_VBN in_IN gold-conjugated_JJ
          secondary_JJ antibodies_NNS (_( 10_CD nm_NN gold_NN anti-mouse_JJ and_CC 5_CD nm_NN gold_NN
          anti-rabbit_JJ )_) for_IN 1_CD hour_NN ,_, rinsed_JJ 3_CD times_NNS in_IN TBS_NNP ,_, fixed_VBN in_IN
          2_CD %_NN glutaraldehyde_NN ,_, rinsed_JJ 3_CD times_NNS in_IN TBS_NNP ,_, rinsed_JJ in_IN
          water_NN ,_, stained_JJ with_IN Reynold_NNP =_SYM s_VBZ lead_VB citrate_NN followed_VBN by_IN
          aqueous_JJ 2_CD %_NN uranyl_NN acetate_NN ,_, dried_VBD on_IN filter_NN paper_NN and_CC
          viewed_VBN using_VBG a_DT Philips_NNP CM_NNP 10_CD transmission_NN electron_NN
          microscope_NN ._. The_DT following_VBG antibodies_NNS and_CC sera_NN were_VBD used_VBN ,_,
          normal_JJ rabbit_NN serum_NN (_( Vector_NNP Laboratories_NNPS Inc_NNP ._. ,_,
          Burlingame_NNP ,_, CA_NNP )_) ,_, rabbit_NN polyclonal_NN anti-_NN SOD_NNP 1_CD [_NN 86_CD ]_NN ,_, a_DT
          second_JJ rabbit_NN polyclonal_NN anti-_NN SOD_NNP 1_CD (_( Biodesign_NNP ,_, Saco_NNP ,_, ME_NNP )_)
          and_CC a_DT mouse_NN monoclonal_NN antibody_NN against_IN CO_NNP 1_CD ._. All_DT
          antibodies_NNS and_CC serum_NN were_VBD used_VBN at_IN a_DT 1_CD :_: 10_CD dilution_NN ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        CMJH_NNP carried_VBD out_IN immunofluorescence_NN and_CC EM_NNP ,_, analyzed_VBD
        data_NNS ,_, made_VBN figures_NNS and_CC drafted_VBD the_DT manuscript_NN ._. CWJ_NNP assisted_VBN
        in_IN immunofluorescence_NN and_CC EM_NNP ._. ZX_NNP carried_VBD out_IN
        immunofluorescence_NN and_CC EM_NNP ,_, analyzed_VBD data_NNS ,_, made_VBN figures_NNS and_CC
        wrote_VBD the_DT manuscript_NN ._.
      
    
  
